$CANSF News

Last published 3y ago

3y agoCANSFWILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCINGPR NewswireCALGARY, AB, Oct. 10, 2023 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of
3y agoCANSFWILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATIONPR NewswireSUNNYVALE, Calif., Oct. 3, 2023 /CNW/ - Willow Biosciences Inc., ("Willow") (TSX:WLLW) (OTCQB:CANSF) and SUANFARMA today jointly announced execution of a collaboration agreement for a cell line productivity
3y agoCANSFWILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCAPR NewswireCompany's BioOxi™ Platform solves for selective C-H hydroxylation, one of the "Holy Grails" of chemistry BioOxi is broadly applicable to manufacturing of intermediates and active pharmaceutical
3y agoCANSFWILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COSTPR NewswireCompany's BioOxi™-based process reduces number of steps and associated costs of corticosteroids manufacturing by up to two-thirds SUNNYVALE, Calif., Aug. 30, 2023 /CNW/ - Willow Biosciences
3y agoCANSFWILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORMPR NewswireAnnounces commercial focus on BioOxiTM bio-oxidation platform as part of targeted alignment on nearer-term and larger revenue opportunities Reduces number of board members as part of geographic transition as a San
3y agoCANSFWILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSPR NewswireSUNNYVALE, Calif., Aug. 21, 2023 /CNW/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and
3y agoCANSFWILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTSPR NewswireNew partnerships and contracts expected to bring in over $1 million in near-term R&D/milestone revenue and generate long term commercial revenue SUNNYVALE, Calif., Aug. 8, 2023 /CNW/ - Willow Biosciences
3y agoCANSFWILLOW AND KALSEC ADVANCE DEVELOPMENT PROGRAM FOR NEW NATURAL FUNCTIONAL INGREDIENT FOR SAVORY FOODSPR NewswireProgram further validates Willow's technology and focus on commercial execution and aligns with its strategic focus on near term revenue generation KALAMAZOO, Mich. and SUNNYVALE, Calif., July 20, 2023 /CNW/ - Willow
3y agoCANSFWILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON JUNE 14PR NewswirePresident and CEO Dr. Chris Savile to provide business update at event open to all investors MOUNTAIN
3y agoCANSFWILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASESPR NewswireBiotech partner recognizes strength of Willow's first in class FutureGrown™ technology platform for producing natural products Further expansion and diversification of Willow's product portfolio with
3y agoCANSFKALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENTPR NewswireRapid success of first collaboration leads to partnership on high-value specialty ingredient Enzyme development expected to enable commercial-scale production in 2024 KALAMAZOO, Mich. and MOUNTAIN VIEW, Calif., May 23,
3y agoCANSFWILLOW BIOSCIENCES REPORTS FIRST QUARTER 2023 RESULTSPR NewswireStarts off year with significant commercial momentum toward focus on delivering robust year-over-year revenue growth for 2023 Previous steps taken to further optimize Willow's business, focus on near-term revenue
3y agoCANSFWILLOW ANNOUNCES COMMERCIAL AGREEMENT WITH SANDHILL ONEPR NewswireCommercial agreement follows the early success on the development phase of the UDCA program with Sandhill One Solid execution on development phases leads to execution of agreement; illustrates company progress against
3y agoCANSFWILLOW ANNOUNCES ROLLOUT OF BioOxi PLATFORM PROVIDING VALUABLE AND EXPEDITED BIOCONVERSION-ENABLED CHEMICAL MANUFACTURINGPR NewswireComplements Company's significant expertise in existing strain engineering and precision fermentation
3y agoCANSFWILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENTPR NewswireWillow Continues its Transition to the Bay Area in California with Management Promotions and a New Board Member MOUNTAIN VIEW, Calif. , March 28, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the
3y agoCANSFWILLOW & SUANFARMA ANNOUNCE COMPLETED DEVELOPMENT AND MANUFACTURING PROCESS FOR CBG AND COMMITMENT TO THE PRODUCTION OF NEW MOLECULES IN A NATURAL WAYPR NewswireCALGARY, AB and MOUNTAIN VIEW, Calif., March 22, 2023 /CNW/ - WILLOW BIOSCIENCES, (TSX:WLLW) (OTCQB:CANSF) and SUANFARMA today jointly announced that they have, together with SUANFARMA's CIPAN manufacturing site,
3y agoCANSFWILLOW ANNOUNCES APPOINTMENT OF DR. JIM LALONDE TO BOARD OF DIRECTORSPR NewswireDr. Lalonde has pioneered key advancements in enzyme engineering and biocatalysis that has revolutionized chemical production, protein engineering for food and nutrition, as well as drug discovery and development leading
3y agoCANSFWILLOW ANNOUNCES FOLLOW-ON ENGAGEMENT FOR NEXT PHASE OF PARTNERED PHARMACEUTICAL PROJECTPR NewswireRepresents early progress against targeted milestones anticipated for 2023 to expand company growth CALGARY, AB and MOUNTAIN VIEW, Calif, Jan. 17, 2023 /PRNewswire/ - Willow Biosciences Inc. ("Willow")
3y agoCANSFWILLOW PROVIDES CORPORATE UPDATES, BUSINESS OUTLOOK AND KEY TARGETED MILESTONES ANTICIPATED FOR 2023 TO EXPAND GROWTHPR NewswireCALGARY, AB AND MOUNTAIN VIEW, Calif., Dec. 14, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on
3y agoCANSFWILLOW FURTHER OPTIMIZES ITS BUSINESS TO FOCUS ON NEAR-TERM REVENUE GENERATION AND REDUCE CASH BURNPR NewswireCALGARY, AB and MOUNTAIN VIEW, Calif, Dec. 7, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing
4y agoCANSFKALSEC SIGNS MASTER SERVICES AGREEMENT WITH WILLOW BIOSCIENCES FOR THE DEVELOPMENT AND MANUFACTURE OF FUNCTIONAL FOOD INGREDIENTS USING PRECISION FERMENTATIONPR NewswireKALAMAZOO, Mich. and CALGARY, AB and MOUNTAIN VIEW, Calif., Nov. 8, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing
4y agoCANSFWILLOW BIOSCIENCES TO HOST INVESTOR PRESENTATION WEBCASTPR NewswireCALGARY, AB AND MOUNTAIN VIEW, Calif, Nov. 7, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing
4y agoCANSFWILLOW BIOSCIENCES REPORTS THIRD QUARTER 2022 RESULTS AND ANNOUNCES APPOINTMENT OF DR SEUFER-WASSERTHAL AS PRESIDENT AND CEOPR NewswireCALGARY, AB AND MOUNTAIN VIEW, CA, Nov. 3, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX:WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing
4y agoCANSFWILLOW BIOSCIENCES ANNOUNCES NEW FUNCTIONAL INGREDIENT ASTAXANTHIN ADDED TO PRODUCT PORTFOLIOPR NewswireCALGARY, AB and MOUNTAIN VIEW, Calif., Oct. 12, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX:WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing
4y agoCANSFWILLOW BIOSCIENCES PROVIDES CBG UPDATEPR NewswireCALGARY, AB and MOUNTAIN VIEW, Calif, Aug. 31, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and
4y agoCANSFWILLOW BIOSCIENCES REPORTS SECOND QUARTER 2022 RESULTSPR NewswireCALGARY, AB AND MOUNTAIN VIEW, CA, Aug. 15, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and su
4y agoCANSFWILLOW BIOSCIENCES APPOINTS DR. PETER SEUFER-WASSERTHAL AS INTERIM PRESIDENT AND CEOPR NewswireCALGARY, AB and MOUNTAIN VIEW, Calif. , July 18, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent
4y agoCANSFWILLOW BIOSCIENCES INCORPORATES INSCRIPTA'S ONYX® PLATFORM TO EXPAND STRAIN ENGINEERING CAPABILITIES AND THROUGHPUTPR NewswireCALGARY, AB and MOUNTAIN VIEW, Calif., June 6, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and
4y agoCANSFWILLOW BIOSCIENCES EXPANDS ITS PORTFOLIO WITH A NEW PARTNERED PHARMACEUTICAL PROJECTPR NewswireCALGARY, AB and MOUNTAIN VIEW, Calif., May 31, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent and
4y agoCANSFWILLOW BIOSCIENCES ANNOUNCES EXPANSION OF ITS FERMENTATION MANUFACTURING NETWORK AND PROGRESS ON ITS CBG GRAS DETERMINATIONPR NewswireVANCOUVER, BC, May 11, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX:WLLW) (OTCQB:CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of high-value molecules traditionally derived fr
4y agoCANSFWILLOW BIOSCIENCES TO HOST INVESTOR PRESENTATION WEBCASTPR NewswireVANCOUVER, BC, Jan. 31, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX:WLLW) (OTCQB:CANSF), a leading biotechnology company that manufactures pure, consistent and sustainable cannabinoids via yeast biosynthesis, today anno
4y agoADRNY ALVOF ANKOF ARREF+55OTC Markets Group Announces Quarterly Index Performance and RebalancingGlobeNewswireNEW YORK, Jan. 25, 2022 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX:OTCM), operator of financial markets for 11,000 U.S. and global securities, today announced the fourth quarter 2021 performance and quarterly rebalancing of the OTCQX® and OTCQB
4y agoCANSFWILLOW BIOSCIENCES PUBLISHES THE FIRST PEER REVIEWED ARTICLE DEMONSTRATING THE CLINICAL BENEFIT OF CBG FOR SKINCAREPR NewswireVANCOUVER, BC, Jan. 19, 2022 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:CANSF), a leading biotechnology company that manufactures pure, consistent and sustainable cannabinoids via yeast biosynthesis, is please
4y agoCANSFWillow Biosciences Reports Third Quarter 2021 ResultsPR NewswireVANCOUVER, BC, Nov. 15, 2021 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB:CANSF) has released its financial and operating results for the three and nine months ended September 30, 2021, reporting significant a
5y agoCANSFWillow Biosciences Announces Commercial Scale Operational Update, CBGA Production Update and Corporate UpdatePR NewswireVANCOUVER, BC, Sept. 21, 2021 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX:CANSF), a leading biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthesis, is
5y agoAVCNF BABYF CANSF FLHLF+2Life Sciences Companies Investor Presentations Now Available for On-Demand ViewingGlobeNewswireNEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the September 16th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcase
5y agoCANSFWillow Biosciences Inc. to Webcast Live at Life Sciences Investor Forum September 16thGlobeNewswireVANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Willow Biosciences Inc. (TSX:WLLW, OTCQX:CANSF), based in Vancouver, Canada and is a leading biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast
5y agoAVCNF BABYF CANSF FLHLF+2Life Sciences Virtual Investor Conference: Company Executives Present Live September 16thGlobeNewswireNEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will
5y agoCANSFWillow Biosciences Announces Expansion of its Commercial Operations Team and Development Portfolio, an Update on its Intellectual Property Position, and Formation of ESG CommitteePR NewswireVANCOUVER, BC, July 20, 2021 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX:CANSF), a leading biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthesis, is
5y agoAGCBF AGGFF BNVIF CANSF+22Proactive news headlines Amarillo Gold, Deep South Resources, Harvest One and Green Battery MineralsGlobeNewswireNew York , June 10, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Lingo Media Corporation (CVE:LM) (OTC:LMDCF)
5y agoCANSFWillow Biosciences Announces Participation In Synbiobeta Panel DiscussionPR NewswireVANCOUVER, BC, May 25, 2021 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX:CANSF), a Canadian biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthesis, is
5y agoALPP AMYZF ASWRF BLONF+21Proactive news headlines including Mountain Valley MD Holdings, Viscount Mining, CytoDyn and Gungnir ResourcesGlobeNewswireNew York, May 18, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Mountain Valley MD Holdings Inc (CSE:MVMD) (OTCQB:
5y agoCANSF THCXWillow Biosciences Added to NYSE-Listed Cannabis ETF "THCX"PR NewswireVANCOUVER, BC, May 18, 2021 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX:CANSF), a Canadian biotechnology company that manufactures ultra-pure, sustainably produced cannabinoids via yeast-based biosynthesis, ann
5y agoALPP CANSF DSMTF FUNFF+15Proactive news headlines including Numinus Wellness, Organic Garage, GoviEx Uranium, Ipsidy and Arcadia BiosciencesGlobeNewswireNew York , May 10, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Numinus Wellness Inc (CVE:NUMI) congratulates
5y agoCANSF CCWOF CLGUF CODX+21Proactive news headlines including Vuzix Corp, Cloud Nine Web3 Technologies, Fury Gold Mines and Dalrada FinancialGlobeNewswireNew York, April 20, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: Vuzix Corporation (NASDAQ:VUZI) says Verizon's
5y agoCANSF CSE:WLLWWillow Biosciences Announces Ground-Breaking Scientific Data for Cannabigerol (CBG) on Human SkinPR NewswireVANCOUVER, BC, April 20, 2021 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQX:CANSF) is pleased to announce that it has completed a series of studies with its development partner, Signum Biosciences, Inc., that de